Get the Stockscreener App
0.00
100.00%
-2.07
Immunoprecise Antibodies Ltd stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
ImmunoPrecise Antibodies Ltd is an AI-driven biotherapeutic research, technology and scientifically robust life science company focused on the discovery and development of next-generation biologics. The Company combines scientific expertise with proprietary technologies such as its LENSai platform to accelerate drug discovery and improve decision-making across complex biological systems. IPA has several subsidiaries in North America and Europe, supporting global partners in advancing novel therapeutics, diagnostics, and translational research.
See More
Previous Close:
$2.07
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$89.08M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
0.00
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.2459
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
Name
Immunoprecise Antibodies Ltd
Sector
Industry
Phone
-
Address
-
Compare IPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
0.00 | 89.08M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd Stock (IPA) Latest News
Why ImmunoPrecise Antibodies Ltd. stock is considered a top pickVolume Spike & Precise Buy Zone Identification - newser.com
Will ImmunoPrecise Antibodies Ltd. (TQB) stock sustain dividend payoutsJuly 2025 Catalysts & Consistent Income Trade Recommendations - newser.com
How sentiment analysis helps forecast ImmunoPrecise Antibodies Ltd.Trade Risk Summary & Detailed Earnings Play Alerts - newser.com
Can ImmunoPrecise Antibodies Ltd. stock surprise with earnings upsideQuarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com
Intraday pattern recognizer results for ImmunoPrecise Antibodies Ltd.2025 Support & Resistance & Growth Focused Investment Plans - newser.com
Is ImmunoPrecise Antibodies Ltd. (TQB) stock a defensive play amid uncertaintyWeekly Market Report & Safe Entry Point Alerts - newser.com
How to manage a losing position in ImmunoPrecise Antibodies Ltd.Weekly Stock Report & Consistent Return Investment Signals - newser.com
Is ImmunoPrecise Antibodies Ltd. stock a defensive play in 2025Portfolio Gains Report & Consistent Income Trade Ideas - newser.com
Does ImmunoPrecise Antibodies Ltd. stock trade at a discount to peersJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Why ImmunoPrecise Antibodies Ltd. stock could see breakout soonQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
What earnings revisions data tells us about ImmunoPrecise Antibodies Ltd.Chart Signals & High Win Rate Trade Tips - newser.com
Will ImmunoPrecise Antibodies Ltd. stock recover faster than peersMarket Performance Recap & Fast Exit and Entry Strategy Plans - newser.com
Will earnings trigger a reversal in ImmunoPrecise Antibodies Ltd.July 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Why ImmunoPrecise Antibodies Ltd. stock is recommended by analystsTake Profit & Weekly Breakout Watchlists - newser.com
Can ImmunoPrecise Antibodies Ltd. stock hit record highs againQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Can ImmunoPrecise Antibodies Ltd. (TQB) stock deliver double digit returnsJuly 2025 Action & Smart Swing Trading Techniques - newser.com
Is ImmunoPrecise Antibodies Ltd. stock a bargain at current levelsQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
What high frequency data says about ImmunoPrecise Antibodies Ltd.Weekly Investment Recap & Smart Swing Trading Alerts - newser.com
What analyst consensus says on ImmunoPrecise Antibodies Ltd. stock2025 Macro Impact & Technical Confirmation Alerts - newser.com
When is the best time to exit ImmunoPrecise Antibodies Ltd.2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com
Can ImmunoPrecise Antibodies Ltd. stock deliver strong Q4 earningsEarnings Growth Report & Verified Technical Signals - newser.com
What makes ImmunoPrecise Antibodies Ltd. (TQB) stock appealing to growth investorsTrade Risk Summary & Stepwise Entry and Exit Trade Signals - newser.com
Can ImmunoPrecise Antibodies Ltd. recover in the next quarter2025 Volatility Report & Technical Entry and Exit Tips - newser.com
Published on: 2025-11-01 06:39:21 - newser.com
Will ImmunoPrecise Antibodies Ltd. (TQB) stock profit from fiscal stimulusWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
Immunoprecise Antibodies Ltd Stock (IPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):